Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to f…


CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic ins…


Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch…

POPULAR TAGS

Undizzy you by crowdfunding “Dizzy Me”

Written by DS on in the category news with the tags , .


Tania Stadsbader, a patient who suffered more than 10 years from dizziness, and Floris Wuyts, professor in Physics at UA, head of AUREA (Antwerps Universitair Researchcentrum voor Evenwicht) and Aerospace at UZA, together wrote the book “Dizzy me. Licht op evenwicht”. The book explains the difference between 12 pathologies of dizziness to doctors and patients, how to recognize them and how to make a correct diagnosis. This leads to the right treatment. The unique cooperation between a patient and a professor led to the publication of an original scientific work, however for the moment it is only available in Dutch.

Therefore, the duo started a crowdfunding campaign to raise the necessary funds to translate this book into English. They want to share it with the world.
The campaign still runs for five days, and you can contribute here:

www.ulule.com/dizzy-me

BioVox will raffle three books among its readers. Follow us on Twitter or LinkedIn to get to know how!

Also, have a look at the research activities of Prof. Wuyts in this video. He compared brain scans from astronauts before and after their space journey.

Read more about: , .

RELATED ARTICLES
The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to f…


CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic ins…


Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Itera Life Science UGent GSK V-Bio Ventures XpandInnovation KU Leuven Turnstone Biowin Janssen Flanders.bio

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.